• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用单克隆抗体TS 106对胸苷酸合酶-FdUMP-5,10-亚甲基四氢叶酸三元复合物进行免疫定量分析。

Immunological quantitation of thymidylate synthase-FdUMP-5,10-methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106.

作者信息

Drake J C, Allegra C J, Johnston P G

机构信息

NCI-Navy Medical Oncology Branch, National Cancer Institute, NIH, Naval Medical Hospital, Bethesda, MD 20889-5105.

出版信息

Anticancer Drugs. 1993 Aug;4(4):431-5. doi: 10.1097/00001813-199308000-00002.

DOI:10.1097/00001813-199308000-00002
PMID:8400344
Abstract

Thymidylate synthase (TS) is responsible for the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate. One of the principal mechanisms of action of 5-fluorouracil (5-FU) is the inhibition of TS by formation of a ternary covalent complex consisting of TS-5-fluorodeoxyuridylate-5,10-methylenetetrahydrofolate. We have developed a Western immunoblot assay using the monoclonal antibody TS 106 to measure ternary complex and free TS in intact human carcinoma cells following exposure to either 5-FU alone or 5-FU plus leucovorin. Lysates from cells treated with either 5-FU or 5-FU/leucovorin were resolved in 15% polyacrylamide gel, transferred onto nitrocellulose and immunoblotted using TS 106 antibody. Detection of positive bands was by a chromogenic substrate strain. Immunoblotting detected free TS at 36 kDa and TS in ternary complex at 38.5 kDa which were quantitated by densitometric scanning. This assay was able to detect a ternary complex from intact cells treated with 5-FU or 5-FU/leucovorin up to 96 h after drug removal. The ratio of complex to free TS was up to 2-fold greater in 5-FU/leucovorin-treated cells compared to those treated with 5-FU alone. This assay may be applied to measuring the formation and stability of ternary complex and free TS in patient tissue samples.

摘要

胸苷酸合成酶(TS)负责将脱氧尿苷一磷酸转化为脱氧胸苷一磷酸。5-氟尿嘧啶(5-FU)的主要作用机制之一是通过形成由TS-5-氟脱氧尿苷酸-5,10-亚甲基四氢叶酸组成的三元共价复合物来抑制TS。我们开发了一种使用单克隆抗体TS 106的蛋白质免疫印迹分析方法,以测量完整的人癌细胞在单独暴露于5-FU或5-FU加亚叶酸后三元复合物和游离TS的情况。用5-FU或5-FU/亚叶酸处理的细胞裂解物在15%聚丙烯酰胺凝胶中进行分离,转移到硝酸纤维素膜上,并用TS 106抗体进行免疫印迹。通过显色底物菌株检测阳性条带。免疫印迹检测到36 kDa的游离TS和38.5 kDa的三元复合物中的TS,通过光密度扫描进行定量。该分析方法能够检测在用5-FU或5-FU/亚叶酸处理的完整细胞中直至药物去除后96小时的三元复合物。与单独用5-FU处理的细胞相比,5-FU/亚叶酸处理的细胞中复合物与游离TS的比例高达2倍。该分析方法可用于测量患者组织样本中三元复合物和游离TS的形成和稳定性。

相似文献

1
Immunological quantitation of thymidylate synthase-FdUMP-5,10-methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106.用单克隆抗体TS 106对胸苷酸合酶-FdUMP-5,10-亚甲基四氢叶酸三元复合物进行免疫定量分析。
Anticancer Drugs. 1993 Aug;4(4):431-5. doi: 10.1097/00001813-199308000-00002.
2
Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.使用单克隆抗体TS 106对5-氟尿嘧啶敏感和耐药的人癌细胞系中的胸苷酸合成酶进行免疫定量分析。
Cancer Res. 1992 Aug 15;52(16):4306-12.
3
The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells.5-氟尿嘧啶与亚叶酸之间的剂量及间隔时间对人癌细胞中胸苷酸合酶三元复合物形成的影响。
Br J Cancer. 1995 Jun;71(6):1145-50. doi: 10.1038/bjc.1995.224.
4
Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.接受氟尿嘧啶和亚叶酸治疗患者中胸苷酸合成酶抑制的时间进程。
Semin Oncol. 1992 Apr;19(2 Suppl 3):26-35.
5
Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.亚叶酸钙和α-2a干扰素联合调节氟嘧啶介导的生长抑制作用。
Anticancer Res. 1993 Sep-Oct;13(5A):1335-40.
6
Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.通过在大鼠中反复同时给予草酸钾(Oxo)来保护胃肠道(GI)组织中的胸苷酸合成酶(TS),从而降低5-氟尿嘧啶(5-FU)的胃肠道毒性。
Cancer Chemother Pharmacol. 2000;46(1):51-6. doi: 10.1007/s002800000123.
7
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.5-氟尿嘧啶敏感和耐药的小鼠结肠腺癌中胸苷酸合成酶抑制的体内动力学
Cancer Res. 1982 Feb;42(2):450-6.
8
Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue.定位人细胞和组织细胞质中人类胸苷酸合成酶的单克隆抗体的制备与特性分析
Cancer Res. 1991 Dec 15;51(24):6668-76.
9
The number of 5-fluoro-2'-deoxyuridine-5'-monophosphate binding sites and reduced folate pool in human colorectal carcinoma tissues: changes after tegafur and uracil treatment.人结直肠癌组织中5-氟-2'-脱氧尿苷-5'-单磷酸结合位点数量及叶酸池减少情况:替加氟和尿嘧啶治疗后的变化
Cancer Res. 1995 Sep 1;55(17):3897-901.
10
Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.5-氟尿嘧啶后对胸苷酸合成酶抑制的天然抗性机制
Cancer Res. 1988 Oct 15;48(20):5894-900.

引用本文的文献

1
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions.条件致死性分析揭示了抗癌作用机制和药物-营养物相互作用。
Sci Adv. 2024 Oct 4;10(40):eadq3591. doi: 10.1126/sciadv.adq3591.
2
The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.乳腺癌细胞中对5-氟尿嘧啶耐药的潜在机制及其通过抑制胸苷磷酸化酶实现的逆转。
Oncol Lett. 2022 Jul 15;24(3):311. doi: 10.3892/ol.2022.13431. eCollection 2022 Sep.
3
Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1.
漆酚V通过下调FoxM1抑制人结肠癌细胞增殖并增强5-氟尿嘧啶的抗肿瘤活性。
Biomol Ther (Seoul). 2022 May 1;30(3):257-264. doi: 10.4062/biomolther.2022.008.
4
Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil.胸苷酸合成酶对5-氟脱氧尿苷一磷酸的捕获赋予对5-氟尿嘧啶的抗性。
ACS Omega. 2022 Feb 9;7(7):6046-6052. doi: 10.1021/acsomega.1c06394. eCollection 2022 Feb 22.
5
Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells.HCT116人结肠癌细胞中5-氟尿嘧啶耐药的分子机制及肿瘤生物学方面
Int J Mol Sci. 2021 Mar 13;22(6):2916. doi: 10.3390/ijms22062916.
6
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.结肠癌细胞系中 5FU 代谢相关的获得性 5FU 耐药机制及克服 5FU 耐药的策略。
Oncol Rep. 2021 Apr;45(4). doi: 10.3892/or.2021.7978. Epub 2021 Mar 2.
7
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with Inhibition.阿糖胞苷氟尿苷[10]是一种具有强大抗肿瘤活性的新一代氟嘧啶,与抑制作用具有协同作用。
Mol Cancer Res. 2021 Apr;19(4):565-572. doi: 10.1158/1541-7786.MCR-20-0985. Epub 2021 Feb 16.
8
dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.dUTP 酶抑制可使 DNA 修复缺陷的人类癌细胞对胸苷酸合成酶抑制剂敏感。
Cancer Sci. 2021 Jan;112(1):422-432. doi: 10.1111/cas.14718. Epub 2020 Nov 20.
9
Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability.药代动力学和药效学因素有助于 Let-7c-5p 和 5-氟尿嘧啶在抑制肝癌细胞活力方面的协同作用。
Drug Metab Dispos. 2020 Dec;48(12):1257-1263. doi: 10.1124/dmd.120.000207. Epub 2020 Oct 13.
10
The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.胸苷磷酸化酶的抑制可以逆转胃癌细胞获得的 5FU 耐药性。
Gastric Cancer. 2019 May;22(3):497-505. doi: 10.1007/s10120-018-0881-3. Epub 2018 Oct 1.